When was Probius founded?

Probius was founded in 2016 and raised its 1st funding round 9 years after it was founded.

Where is Probius located?

Probius is headquartered in Fremont, United States.

Who is the current CEO of Probius?

Emmanuel Quevy of Probius. They have also founded 1 company.

How many employees does Probius have?

As of Jun 30, 2026, the latest employee count at Probius is 15.

Is Probius a funded company?

Probius is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Aug 07, 2025.

When was the latest funding round of Probius?

Probius' latest funding was a $***** Seed round on Aug 07, 2025, with participation from 0 investor. Its primary sector is Life Sciences Tech. In United States, the Life Sciences Tech sector has seen $3.34B in funding in 2026 to date.

Where does Probius rank among its competitors?

Probius ranks 10th amongst 182 active competitors, of which 43 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Cartography Biosciences, which secured an undisclosed amount in May, 2026.

Who are the top competitors of Probius?

Probius' top competitors include Certara, Cartography Biosciences and TOLREMO therapeutics. Among them, Cartography Biosciences secured the most recent funding round in May, 2026.

Probius - 2026 Company Profile, Team, Funding & Competitors

Company Details

Digital biochemical analysis tool for healthcare researchers. The company has developed software that assists with biological sample management and biochemical data analysis. It has features for sample analysis, data intelligence, cloud-based phenotypic data analysis, and more.

Website: www.probius.bio/
Social
Email ID: *****@probiusdx.com
Phone Number: +1 **********

Key Metrics

Founded Year

2016

Location

Fremont, United States

Stage

Seed

Total Funding

$2.44M in 1 round

Latest Funding Round

Seed, Aug 07, 2025, $*****

Investors

Cota Capital & 9 more

Ranked

10^th among 182 active competitors

Employee Count

15 as on Jun 30, 2026

Similar Companies

Certara & 248 more

View Probius' full profile

Probius has raised a total funding of $2.44M over 1 round. Probius has 10 institutional investors.

Here is the list of recent funding rounds of Probius:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 07, 2025	1231566	Seed	3302784	2828316	4742330	1218731

Access funding benchmarks and valuations. Sign up today!

View details of Probius's funding rounds and investors

The founders of Probius are Emmanuel Quevy and Roger Howe. Emmanuel Quevy is the CEO of Probius.

Here are the details of Probius' key team members:

Emmanuel Quevy: Co-Founder & CEO of Probius and founder of 1 other company.
Contact Info: 1 email address
Roger Howe: Co-Founder of Probius.

View details of Probius's Founder profiles and Board Members

Probius' employee count trend

Probius has 15 employees as of Jun 26. Here is Probius's employee count trend over the years:

Uncover Probius' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Probius include Certara, Cartography Biosciences and TOLREMO therapeutics. Here is the list of Top 10 competitors of Probius, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Certara 2008, Princeton (United States), Public	Provider of a platform for in silico drug discovery and consulting services	-	HTIF, Mubadala & 3 others	65/100
2nd	Cartography Biosciences 2020, Foster City (United States), Series B	Provider of a platform to discover immunotherapeutics	$124M	8VC, Pfizer & 19 others	62/100
3rd	TOLREMO therapeutics 2017, Zurich (Switzerland), Series A	Developing anti-cancer small molecules targeting novel drug resistance pathways	$55.8M	BioMedPartners, Altos Ventures Management ... & 9 others	60/100
4th	Astex Pharmaceuticals 1991, Pleasanton (United States), Acquired	Oncology and CNS drug discovery and development using cutting-edge technology	$3M	New Enterprise Associates, Saints Capital ... & 6 others	60/100
5th	Pharmacelera 2015, Barcelona (Spain), Series A	Hardware and software solutions for computer-aided drug design	$7.1M	HERAN Partners, The Collider & 6 others	59/100
6th	Oxford Drug Design 2001, Oxford (United Kingdom), Series A	Provider of computer-aided design of antibiotics for MDR infections	$12.4M	o2h ventures, ACF Investors & 55 others	59/100
7th	Inpharmatica 1998, London (United Kingdom), Acquired	Developer of predictive informatics based platform for drug discovery	$75M	Vertex Ventures, Kreos Capital & 6 others	58/100
8th	Genialis 2015, Boston (United States), Series A	Developer of end-to-end bioinformatics software solutions	$16M	Taiwania Capital, Debiopharm & 9 others	56/100
9th	CytoReason 2016, Haifa (Israel), Series C	Discovering immune system based drugs by biological data analytics	$130M	Pfizer, Nvidia & 9 others	55/100
10th	Probius 2016, Fremont (United States), Seed	Digital biochemical analysis tool for healthcare researchers	$2.44M	Cota Capital, Sand Hill Angels & 8 others	53/100